Moreover, the authors suggested that a high HRD score (>0.70), using HRDetect assay, was predictive of lung cancer cell line sensitivity to olaparib and talazoparib, suggesting a possible role of PARP inhibitors in a select population [46]. The gene discussed is PARP1; the disease is lung cancer.